We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Detection of Ribonucleic Acids Improved For Molecular Diagnostics

By LabMedica International staff writers
Posted on 21 Dec 2011
A new protocol for the detection of short ribonucleic acids (RNA) known as micro-RNA (miRNA) will help isolate sufficient quantities for diagnostic purposes. More...


The method shows how effectively collecting blood plasma samples, brings a step closer the goal of making miRNA disease diagnostics a reality as the choice of blood collection tube affects quantitation.

A study carried out at the Rosalind Franklin University of Medicine and Science. (Chicago, IL, USA) determined what factors can interfere with the accuracy of miRNA tests The scientists provided clear procedures for the collection and analysis of miRNA, significantly improving their diagnostic accuracy. MicroRNAs regulate processes including fertilization, development, and aging show promise as biomarkers of disease.

The authors found that the choice of blood collection tube affects quantitation. Traditional green-top heparin tubes interfered nearly completely with miRNA detection. Grey-top tubes containing the anticoagulant sodium fluoride and potassium oxalate provided the best results. Although miR-16 is about 500 times more abundant in blood plasma than miR-223, the results for both were similar, indicating that the differences in detection resulting from the choice of collection method apply to other miRNAs. Furthermore, collection of miR-223 in serum yielded more variable results, signifying that for some miRNAs, analysis of blood in plasma form is preferred.

The study indicated that natural components of blood plasma co-purify with miRNAs, interfering with their detection. The authors identified extra steps in purification, and the ideal dilution level, to reduce the interference. The investigators avoided the problem of contamination by combining an enzyme that overcomes plasma inhibitors with standard enzymes to increase the sensitivity of miRNA detection by about 30-fold. They also observed that differences in plasma composition among individual donors yield different miRNA measurements.

MicroRNAs can be collected from routinely collected fluids such as blood, saliva, and urine. Over 1,000 miRNAs exist in the human body and deregulation of specific miRNAs is associated with disease. Dominik M. Duelli, PhD, a lead investigator said, "These results raise the possibility that factors including diet, exercise, circadian rhythms, and seasons, which alter the blood chemistry, might affect miRNA detection and quantitation." The study was published online on December 8, 2011, the Journal of Molecular Diagnostics.

Related Links:
Rosalind Franklin University of Medicine and Science


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.